The pompe disease treatment market is anticipated to reach USD 1.538 Billion by 2032 at 3.80% CAGR during the forecast period 2023-2032.
The lack of mutation of the GAA gene causes glycogen buildup, which triggers heart problems, muscular weakness, and liver damage, all of which can lead to early mortality in newborns is increasingly being detected.
Due to various massive...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian